[HTML][HTML] ISTH guidelines for treatment of thrombotic thrombocytopenic purpura

XL Zheng, SK Vesely, SR Cataland, P Coppo… - Journal of Thrombosis …, 2020 - Elsevier
Background Despite advances in treatment options for thrombotic thrombocytopenic purpura
(TTP), there are still limited high quality data to inform clinicians regarding its appropriate …

[HTML][HTML] ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura

XL Zheng, SK Vesely, SR Cataland, P Coppo… - Journal of Thrombosis …, 2020 - Elsevier
Background Despite an increase in our understandings of pathogenesis of thrombotic
thrombocytopenic purpura (TTP), the approaches for initial diagnosis and management of …

Thrombotic thrombocytopenic purpura

BS Joly, P Coppo, A Veyradier - Blood, The Journal of the …, 2017 - ashpublications.org
Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic
microangiopathy characterized by microangiopathic hemolytic anemia, severe …

Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan

M Matsumoto, Y Fujimura, H Wada, K Kokame… - International journal of …, 2017 - Springer
Thrombotic thrombocytopenic purpura (TTP) can rapidly progress into a life-threatening
condition, thus the importance of appropriate diagnosis and treatment cannot be overstated …

Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura

M Scully, A Antun, SR Cataland, P Coppo… - … England Journal of …, 2024 - Mass Medical Soc
Background Congenital thrombotic thrombocytopenic purpura (TTP) results from severe
hereditary deficiency of ADAMTS13. The efficacy and safety of recombinant ADAMTS13 and …

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015

EE Page, JA Kremer Hovinga, DR Terrell… - Blood …, 2017 - ashpublications.org
Our objective was to describe new observations from the Oklahoma Thrombotic
Thrombocytopenic Purpura (TTP) Registry experience (November 1995 through December …

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

F Fakhouri, JP Vernant, A Veyradier, M Wolf… - Blood, 2005 - ashpublications.org
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease that occurs mainly
in young adults. Acquired cases are usually a result of antibodies directed against …

Comparison of the long-term remission of rituximab and conventional treatment for acquired thrombotic thrombocytopenic purpura: a systematic review and meta …

W Owattanapanich, C Wongprasert… - Clinical and Applied …, 2019 - journals.sagepub.com
The current systematic review and meta-analysis aimed to summarize the results of all
available studies to compare the efficacies of rituximab and conventional treatment for …

Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies

JTB Crawley, MA Scully - Hematology 2013, the American …, 2013 - ashpublications.org
VWF is a multimeric plasma glycoprotein that specifically recruits platelets to sites of vessel
injury. VWF multimeric size is central to this function, with larger multimers being more …

Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura

K Dane, S Chaturvedi - Hematology 2014, the American …, 2018 - ashpublications.org
The advent of plasma exchange has dramatically changed the prognosis of acute thrombotic
thrombocytopenic purpura (TTP). Recent insights into TTP pathogenesis have led to the …